BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951
318 results:

  • 1. Application of droplet digital PCR in minimal residual disease monitoring of rare fusion transcripts and mutations in haematological malignancies.
    Ip BBK; Wong ATC; Law JHY; Au CH; Ma SY; Chim JCS; Liang RHS; Leung AYH; Wan TSK; Ma ESK
    Sci Rep; 2024 Mar; 14(1):6400. PubMed ID: 38493200
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/cbfb::MYH11.
    Gao J; Santana-Santos L; Fu L; Alvey E; Chen Q; Wolniak K; Xia Z; Aqil B; Behdad A; Ji P; Sukhanova M; Abaza Y; Altman JK; Chen YH; Lu X
    Eur J Haematol; 2024 Jun; 112(6):964-974. PubMed ID: 38388794
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Acute myeloid leukemia with type I cbfb::MYH11 fusion gene not detected by screening test for leukemia-related chimeric genes].
    Utsumi S; Shima T; Kubara C; Semba Y; Hayashi M; Takigawa K; Yoshino T; Minami M; Matsuo Y; Kuriyama T; Akashi K; Maeda T; Taniguchi S; Eto T
    Rinsho Ketsueki; 2023; 64(12):1503-1507. PubMed ID: 38220149
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mixed-phenotype acute leukemia, T/megakaryoblastic: does it really exist?
    Mansoor N; Javed O; Rafiq N; Aali A; Meraj F
    J Hematop; 2023 Mar; 16(1):49-55. PubMed ID: 38175376
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Therapy-related acute myeloid leukemia with
    Yang X; Liu Q; Zhang R; Yang X; Wang L; Zhang Z; Li Y; Lin L
    Indian J Pathol Microbiol; 2023; 66(4):865-867. PubMed ID: 38084551
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating cbfb::MYH11 oncofusion protein.
    Day RB; Hickman JA; Xu Z; Katerndahl CD; Ferraro F; Ramakrishnan SM; Erdmann-Gilmore P; Sprung RW; Mi Y; Townsend RR; Miller CA; Ley TJ
    J Clin Invest; 2023 Dec; 134(4):. PubMed ID: 38061017
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1.
    Srinivasan S; Dhamne C; Patkar N; Chatterjee G; Moulik NR; Chichra A; Pallath A; Tembhare P; Shetty D; Subramanian PG; Narula G; Banavali S
    Pediatr Blood Cancer; 2024 Feb; 71(2):e30791. PubMed ID: 38014874
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. ATP1A1/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosides.
    Cerella C; Gajulapalli SR; Lorant A; Gerard D; Muller F; Lee Y; Kim KR; Han BW; Christov C; RĂ©cher C; Sarry JE; Dicato M; Diederich M
    Leukemia; 2024 Jan; 38(1):67-81. PubMed ID: 37904054
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Core-binding factor abnormalities involving chromosome 16 in acute myeloid leukaemia: prognostic and therapeutic implications.
    Panigrahi C; Tikare N; Das PK; Padhi S
    BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37591621
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia.
    Duan W; Yang S; Zhao T; Hu L; Qin Y; Jia J; Wang J; Lu S; Jiang H; Zhang X; Xu L; Wang Y; Lai Y; Shi H; Huang X; Jiang Q
    Ann Hematol; 2023 Oct; 102(10):2695-2705. PubMed ID: 37572135
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characterization of leukemia progression in the cbfb-MYH11 knockin mice by single cell RNA sequencing.
    Diemer JL; Yu K; Kelly M; Zhen T; Anderson S; Lopez G; Liu P
    Leukemia; 2023 Jul; 37(7):1549-1553. PubMed ID: 37225965
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia.
    Hara Y; Shiba N; Yoshida K; Yamato G; Kaburagi T; Shiraishi Y; Ohki K; Shiozawa Y; Kawamura M; Kawasaki H; Sotomatsu M; Takizawa T; Matsuo H; Shimada A; Kiyokawa N; Tomizawa D; Taga T; Ito E; Horibe K; Miyano S; Adachi S; Taki T; Ogawa S; Hayashi Y
    Genes Chromosomes Cancer; 2023 Jul; 62(7):412-422. PubMed ID: 37102302
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Prognostic analysis of children with Philadelphia chromosome-like acute lymphoblastic leukemia common genes].
    Hu WD; Li B; Su SF; Liu YF; Liu W; Zhang WL; Zuo WL; Yu RH
    Zhonghua Er Ke Za Zhi; 2023 May; 61(5):446-452. PubMed ID: 37096265
    [No Abstract]    [Full Text] [Related]  

  • 14. Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia.
    Tan Y; Shan L; Zhao L; Deng B; Ling Z; Zhang Y; Peng S; Xu J; Duan J; Wang Z; Yu X; Zheng Q; Xu X; Tian Z; Zhang Y; Zhang J; Chang AH; Feng X; Pan J
    J Hematol Oncol; 2023 Apr; 16(1):34. PubMed ID: 37020231
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
    Liu Y; Klein J; Bajpai R; Dong L; Tran Q; Kolekar P; Smith JL; Ries RE; Huang BJ; Wang YC; Alonzo TA; Tian L; Mulder HL; Shaw TI; Ma J; Walsh MP; Song G; Westover T; Autry RJ; Gout AM; Wheeler DA; Wan S; Wu G; Yang JJ; Evans WE; Loh M; Easton J; Zhang J; Klco JM; Meshinchi S; Brown PA; Pruett-Miller SM; Ma X
    Nat Commun; 2023 Apr; 14(1):1739. PubMed ID: 37019972
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Frequency and pattern of chromosomal abnormalities in acute myeloid leukemia from Western India: A retrospective study.
    Vundinti BR; Korgaonkar S; Dhangar S; Jijina F; Shanmukhaiah C
    J Cancer Res Ther; 2023; 19(2):340-346. PubMed ID: 37006070
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory study.
    Scott S; Dillon R; Thiede C; Sadiq S; Cartwright A; Clouston HJ; Travis D; Mokretar K; Potter N; Chantry A; Whitby L
    Blood Adv; 2023 Jul; 7(14):3686-3694. PubMed ID: 36939402
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comprehensive molecular understanding of pediatric acute myeloid leukemia.
    Shiba N
    Int J Hematol; 2023 Feb; 117(2):173-181. PubMed ID: 36653696
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.
    Cheng WY; Li JF; Zhu YM; Lin XJ; Wen LJ; Zhang F; Zhang YL; Zhao M; Fang H; Wang SY; Lin XJ; Qiao N; Yin W; Zhang JN; Dai YT; Jiang L; Sun XJ; Xu Y; Zhang TT; Chen SN; Zhu HH; Chen Z; Jin J; Wu DP; Shen Y; Chen SJ
    Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2211429119. PubMed ID: 36442087
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Blast phase of chronic myeloid leukemia with concurrent BCR::ABL1 and SET::NUP214: A report of two cases.
    Chen Y; Wang Q; Cen J; Xu C; Tao TT; Xie J; Shen W; Gong Y; Pan J; Yao L
    Mol Carcinog; 2023 Feb; 62(2):117-121. PubMed ID: 36321418
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.